57282 Federal Register / Vol. 75, No. 181 / Monday, September 20, 2010 / Notices 

delivery. The Patient Safety and Quality 

Improvement Final Rule (Patient Safety 

Rule), 42 CFR Part 3, authorizes AHRQ, 

on behalf of the Secretary of HHS, to list 

as a PSO an entity that attests that it 

meets the statutory and regulatory 

requirements for listing. A PSO can be 

‘‘delisted’’ by the Secretary if it is found 

to no longer meet the requirements of 

the Patient Safety Act and Patient Safety 

Rule, including when a PSO chooses to 

voluntarily relinquish its status as a 

PSO for any reason. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12 Midnight 

ET (2400) on April 1, 2010. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http:// 

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Diane Cousins, RPh., Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; E-mail: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity is to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. 

HHS issued the Patient Safety Rule to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule (PDF file, 450 KB. PDF Help) 

relating to the listing and operation of 

PSOs. Section 3108(d) of the Patient 

Safety Rule requires AHRQ to provide 

public notice when it removes a PSO 

from listing. AHRQ has accepted a 

notification from the Florida Patient 

Safety Corporation, PSO number P0001, 

to voluntarily relinquish its status as a 

PSO. Accordingly, the Florida Patient 

Safety Corporation was delisted 

effective at 12 Midnight ET (2400) on 

April 1, 2010. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/ 

index.html. 

Dated: September 3, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–23078 Filed 9–17–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Statement of Organization, Functions 

and Delegations of Authority 

This notice amends Part R of the 

Statement of Organization, Functions 

and Delegations of Authority of the 

Department of Health and Human 

Services (HHS), Health Resources and 

Services Administration (HRSA) (60 FR 

56605, as amended November 6, 1995; 

as last amended at 75 FR 51088–51091 

dated August 18, 2010). 

This notice reflects organizational 

changes in the Health Resources and 

Services Administration. This notice 

updates the functional statement for the 

Office of Special Health Affairs (RA1) 

and the functional statement for the 

Office of Planning, Analysis and 

Evaluation (RA5). Specifically, this 

notice moves the Office of Health 

Information Technology and Quality 

(RA52) from the Office of Planning, 

Analysis and Evaluation (RA5) to the 

Office of Special Health Affairs (RA1); 

abolishes the Office of Data 

Management and Research (RA54) and 

establishes the Office of Research and 

Evaluation (RA56); and eliminates the 

Office of Planning and Evaluation 

(RA51) and moves its functions to the 

Office of Research and Evaluation 

(RA56). 

Chapter RA1—Office of Special Health 

Affairs 

Section RA1–10, Organization 

Delete in its entirety and replace with 

the following: 

The Office is headed by the Director, 

Office of Special Health Affairs (RA1), 

who reports directly to the 

Administrator, Health Resources and 

Services Administration. Office of 

Special Health Affairs includes the 

following components: 

(1) Office of the Director (RA1); 

(2) Office of Health Equity (RA11); 

(3) Office of Global Health Affairs 

(RA12); 

(4) Office of Strategic Priorities 

(RA13); and 

(5) Office of Health Information 

Technology and Quality (RA14). 

Section RA1–20, Functions 

(1) Delete the functional statement for 

the Office of the Director (RA1) and 

replace in its entirety; and (2) establish 

the Office of Health Information 

Technology and Quality (RA14). 

Office of the Director (RA1) 

Provides overall leadership, direction, 

coordination, and planning in the 

support of the Agency’s special health 

programs. Specifically: (1) Plans and 

directs activities to advance health 

equity and improve minority health and 

eliminate health disparities; (2) 

develops strategies to maximize HRSA’s 

participation in efforts to improve 

health care for vulnerable populations 

worldwide; (3) provides leadership and 

direction to improve the delivery and 

quality of oral health care, mental health 

and other priority health concerns; (4) 

provides leadership in the development 

of policies on health information 

technology and quality; and (5) provides 

support for the Department’s Medical 

Claims Review Panel. 

Office of Health Information 

Technology and Quality (RA14) 

Serves as the principal advisor and 

coordinator to the Agency for health 

information technology and quality. 

Specifically: (1) Provides support, 

policy direction, and leadership for 

HRSA’s health quality efforts; (2) serves 

as the focal point for developing policy 

to promote the coordination and 

advancement of health information 

technology, including telehealth, to 

HRSA’s programs, including the use of 

electronic health record systems; (3) 

develops an Agency-wide health 

information technology and telehealth 

strategy for HRSA; (4) assists HRSA 

components in program-level health 

information technology and health 

quality efforts; (5) ensures successful 

dissemination of appropriate 

information technology advances, such 

as electronic health records systems, to 

HRSA programs; (6) works 

collaboratively with States, foundations, 

national organizations, private sector 

providers, as well as departmental 

agencies and other Federal departments 

in order to promote the adoption of 

health information technology and 

health quality policy; (7) ensures the 

health information technology policy 

and activities of HRSA are coordinated 

with those of other HHS components; 

(8) assesses the impact of health 

information technology and quality 

initiatives in the community, especially 

for the uninsured, underserved, and 

special needs populations; (9) translates 

technological advances in health 

information technology to HRSA’s 

programs; (10) provides guidance in 

using the results of the medical claims 

review process to HRSA programs to 

improve quality; and (11) provides 

support for the Department’s Medical 

Claims Review Panel. 


jdjones on DSK8KYBLC1PROD with NOTICES
Federal Register / Vol. 75, No. 181 / Monday, September 20, 2010 / Notices 57283 

Chapter RA5—Office of Planning, 

Analysis and Evaluation 

Section RA5–10, Organization 

Delete in its entirety and replace with 

the following: 

The Office is headed by the Director, 

Office of Planning, Analysis and 

Evaluation (RA5), who reports directly 

to the Administrator, Health Resources 

and Services Administration. Office of 

Planning, Analysis and Evaluation 

includes the following components: 

(1) Office of the Director (RA5); 

(2) Office of Policy Analysis (RA53); 

and 

(3) Office of Research and Evaluation 

(RA56). 

Section RA5–20, Functions 

(1) Delete the functional statement for 

the Office of the Director (RA5) and 

replace in its entirety; and (2) delete the 

functional statement for the Office of 

Data Management and Research (RA54) 

and replace with the newly established 

Office of Research and Evaluation 

(RA56). 

Office of the Director (RA5) 

(1) Provides Agency-wide leadership 

for policy development, data collection 

and management, major analytic 

activities, research, and evaluation; (2) 

develops HRSA-wide policies; (3) 

participates with HRSA organizations in 

developing strategic plans for their 

component; (4) coordinates the 

Agency’s long term strategic planning 

process; (5) conducts and/or guides 

analyses, research, and program 

evaluation; (6) analyzes budgetary data 

with regard to planning guidelines; (7) 

coordinates the Agency’s 

intergovernmental activities; (8) 

maintains liaison between the 

Administrator, other OPDIVs, Office of 

the Secretary staff components, and 

other Departments on critical matters 

involving analysis of program policy 

undertaken in the Agency; (9) prepares 

policy analysis papers and planning 

documents as required; and (10) 

collaborates with Office of Operations in 

the development of budgets, 

performance plans, and other 

administration reporting requirements. 

Office of Research and Evaluation 

(RA56) 

(1) Serves as the principal source of 

leadership and advice on program 

information and research; (2) analyzes 

and coordinates the Agency’s need for 

information and data for use in the 

management and direction of Agency 

programs; (3) manages an Agency-wide 

information and data group as well as 

an Agency-wide research group; (4) 

maintains an inventory of HRSA 

databases; (5) provides technical 

assistance to HRSA staff in database 

development, maintenance, analysis, 

and distribution; (6) promotes the 

availability of HRSA data through web 

sites and other on-line applications; (7) 

conducts, oversees, and fosters high 

quality research across HRSA 

programmatic interests; (8) develops an 

annual research agenda for the Agency; 

(9) conducts, leads, and/or participates 

with HRSA staff in the development of 

research and demonstration projects; 

(10) coordinates HRSA participation in 

institutional review boards and the 

protection of human subjects; (11) 

conducts, guides, and/or participates in 

major program evaluation efforts and 

prepares reports on HRSA program 

efficiencies; (12) develops annual 

performance plans; (13) analyzes 

budgetary data with regard to planning 

guidelines; (14) develops and produces 

performance reports required under the 

Government Performance and 

Accountability Report and OMB; and 

(15) manages HRSA activity related to 

the Paperwork Reduction Act, and other 

OMB policies. 

Section RA–30, Delegations of Authority 

All delegations of authority and redelegations of authority made to HRSA 

officials that were in effect immediately 

prior to this reorganization, and that are 

consistent with this reorganization, 

shall continue in effect pending further 

re-delegation. 

This reorganization is upon date of 

signature. 

Dated: September 14, 2010. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2010–23429 Filed 9–17–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. CUSTOMS AND BORDER 

PROTECTION 

Agency Information Collection 

Activities: Passenger and Crew 

Manifest 

AGENCY: U.S. Customs and Border 

Protection, Department of Homeland 

Security. 

ACTION: 30–Day notice and request for 

comments; Revision of an existing 

information collection: 1651–0088. 

SUMMARY: U.S. Customs and Border 

Protection (CBP) of the Department of 

Homeland Security will be submitting 

the following information collection 

request to the Office of Management and 

Budget (OMB) for review and approval 

in accordance with the Paperwork 

Reduction Act: Passenger and Crew 

Manifest (Advance Passenger 

Information System–APIS). This is a 

proposed extension of an information 

collection that was previously 

approved. CBP is proposing that this 

information collection be extended with 

a change to the burden hours. This 

document is published to obtain 

comments from the public and affected 

agencies. This proposed information 

collection was previously published in 

the Federal Register (75 FR 42115) on 

July 20, 2010, allowing for a 60-day 

comment period. This notice allows for 

an additional 30 days for public 

comments. This process is conducted in 

accordance with 5 CFR 1320.10. 

DATES: Written comments should be 

received on or before October 20, 2010. 

ADDRESSES: Interested persons are 

invited to submit written comments on 

this proposed information collection to 

the Office of Information and Regulatory 

Affairs, Office of Management and 

Budget. Comments should be addressed 

to the OMB Desk Officer for Customs 

and Border Protection, Department of 

Homeland Security, and sent via 

electronic mail to 

oira_submission@omb.eop.gov or faxed 

to (202) 395–5806. 

SUPPLEMENTARY INFORMATION: 

U.S. Customs and Border Protection 

(CBP) encourages the general public and 

affected Federal agencies to submit 

written comments and suggestions on 

proposed and/or continuing information 

collection requests pursuant to the 

Paperwork Reduction Act (Pub. L.104– 

13). Your comments should address one 

of the following four points: 

(1) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency/component, 

including whether the information will 

have practical utility; 

(2) Evaluate the accuracy of the 

agencies’/components’ estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collections of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

techniques or other forms of 

information. 


jdjones on DSK8KYBLC1PROD with NOTICES